热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 来源：国投期货 South32 South32在2025年四季度锰矿产量为136.3万吨，同比增加21.26%，环比下降2.99%。澳洲矿山2026财年 产量计划仍然为320万吨。南非矿山生产目标维持200万吨。 Eramet-Comilog Comilog四季度产量为168万吨，同比抬升35.81%，环比下降10.35%。由于铁路运输仍存问题，锰矿运 输量较难抬升高水平。 整体来看，Comilog较难上调发运目标，我国锰矿累库水平相对一般，锰矿价格较难大幅下行。 表1：两大矿山产销数据（万吨） 澳大利亚产区在2026财年上半年可销售产量增至166万吨，得益于热带气旋"梅根"影响后复产计划的顺 利执行，该运营单元实现了规划产量。2026财年产量指引维持在320万吨不变，具体取决于雨季可能带 来的影响。随着新码头基础设施投入使用，2026财年上半年销量增至181万吨，发运能力已达满负荷状 态，从而实现了计划中的库存消耗。 南非产区在2026财年上半年可销售产量同比减少2%（2.5万吨）至106万吨，主要反映了Wessels矿山的 计划性维护及深部 ...

Group 1: Strategic Transformation and Investment - Gansu Jinchang's Jinche Storage Energy has successfully restarted its 18GWh sodium-ion battery project, shifting from lithium iron phosphate technology to sodium-ion technology, with a total investment of 6.115 billion yuan and an expected annual output value of 10.8 billion yuan upon full production [1] - The project exemplifies Jinchang's commitment to leading industrial transformation and upgrading through technological innovation, with the city's comprehensive technological progress index reaching 72.4% in 2024, an increase of 14.35 percentage points since 2021 [1] Group 2: Breakthrough Innovations - Jinchuang Group has implemented a remote mineral clearing system that enhances efficiency by 40%, reducing the time for mineral clearing from 2 hours to 10 minutes, serving as a replicable model for intelligent transformation in the industry [2] - Gansu Yuansheng Agricultural Technology has developed a new breed of sheep that is high-yielding and well-suited to the Northwest climate, laying a solid foundation for Jinchang to become the "City of Dairy Sheep" [2] Group 3: Enhanced Corporate Development - Gansu Jinchuan Hengxin Polymer Technology has achieved a breakthrough in the resource recovery of acidic wastewater, increasing chloride ion utilization from 50% to over 95%, and has been awarded the 2024 Gansu Provincial Science and Technology Progress Award [3] - Jinchang has established a diversified innovation support system, with a significant increase in high-tech enterprises from 36 in 2020 to 87 currently, supported by financial incentives and hands-on assistance for R&D [3] Group 4: Financial Support for Innovation - Jinchang has introduced the "Sci-Tech Loan" service model, providing over 100 million yuan in loans to more than 20 enterprises, facilitating new product development and equipment upgrades [4] - The city has also seen significant results from its intellectual property pledge financing, totaling 9.02 million yuan, effectively turning intellectual property into assets for enterprises [4] Group 5: Promoting Industrial Innovation - Jinchang's key laboratory has made significant progress in developing critical structural materials for the fourth-generation nuclear energy system, supporting the localization of key nuclear materials [5] - The city has accelerated the construction of innovation platforms, with new technology innovation centers and agricultural science parks established, and has formed innovation alliances to strengthen the foundation for industrial innovation [5] - The implementation of technology specialists and agricultural technology representatives has significantly enhanced the innovation capabilities of enterprises [5]

Group 1 - The Trump administration plans to utilize the Pentagon's AI project to establish reference prices for critical minerals, supporting the creation of a global metal trading group [1][4] - The reference prices will be developed by the U.S. Department of Defense's OPEN AI metal project, initially focusing on germanium, gallium, antimony, and tungsten, with plans to expand coverage [1][4] - The implementation timeline for the reference prices remains unclear, as the Trump administration must first persuade numerous allied countries to join the trading group to ensure the mechanism's effectiveness [1] Group 2 - The OPEN project, initiated in 2023, aims to incorporate labor, processing, and other costs into metal pricing calculations, focusing on metals with low liquidity or no public market [4] - The project is expected to be transferred to the non-profit Critical Minerals Forum (CMF) next year, which will conduct AI model stress tests and support commercially viable mining projects [4] Group 3 - The combination of reference prices and adjustable tariffs presents multiple unresolved issues regarding its operational mechanics, including whether prices will fluctuate with the market or remain fixed [5] - There are uncertainties about the scope of tariffs, particularly whether they will apply to all end products containing critical minerals, as manufacturers typically prefer to source raw materials at the lowest prices [5] Group 4 - U.S. mining companies generally support the reference price and tariff proposal, provided it helps them achieve profitability, with specific demands for reference prices to be above production costs [6] - There is increasing attention on price transparency in the mineral market, with reports of CME Group planning to launch the first global rare earth futures contract [6]

Group 1 - The core viewpoint of the news is that Shan Jin International (000975) has shown significant financial growth in its recent quarterly report, with a notable increase in both revenue and net profit [2] - As of February 24, 2026, Shan Jin International's stock closed at 30.71 yuan, reflecting a 4.0% increase, with a trading volume of 374,600 hands and a total transaction amount of 1.152 billion yuan [1] - The company reported a main revenue of 14.996 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 24.23%, and a net profit attributable to shareholders of 2.46 billion yuan, up 42.39% year-on-year [2] Group 2 - In the third quarter of 2025, Shan Jin International achieved a single-quarter main revenue of 5.75 billion yuan, which is a 3.3% year-on-year increase, and a net profit of 864 million yuan, reflecting a 32.43% increase year-on-year [2] - The company has a debt ratio of 19.16%, with investment income of 10.58 million yuan and financial expenses of 30.25 million yuan, resulting in a gross profit margin of 28.39% [2] - Over the past 90 days, four institutions have provided ratings for the stock, with three giving a "buy" rating and one an "increase" rating, while the average target price set by institutions is 26.75 yuan [2]

Group 1 - Barclays has lowered its target price for Rio Tinto from 6,885 pence to 6,600 pence, changing the rating from "Overweight" to "Hold" [1] - Analysts believe that iron ore prices are nearing seasonal peaks, which typically leads to a gradual decline until the fourth quarter, indicating a potential weakening in Rio Tinto's earnings momentum [1]

Market Overview - A-shares showed resilience during the Chinese New Year holiday, while Hong Kong stocks fell by 1.82% upon reopening, indicating market pressure [1] - The performance of Hong Kong stocks during the holiday included a significant rise in robotics stocks, such as Yujian (02432), which surged nearly 24% before returning to previous levels due to the limitations of current technology [1] - The AI sector saw mixed reactions, with companies like Zhiyu (02513) and MiniMax (00100) showing strong performance due to advancements in their models, while concerns about the broader implications of AI on various industries led to declines in many application stocks [4][5] U.S. Trade Policies - The U.S. Supreme Court ruled that the government's tariffs under the International Emergency Economic Powers Act lacked clear legal authority, leading to the termination of several tariff measures [2] - In response, former President Trump announced an increase in global import tariffs from 10% to 15%, effective immediately, which may negatively impact countries like the UK and Japan that previously benefited [2] Middle East Tensions - The U.S. military has deployed two aircraft carrier strike groups in the Middle East, marking the largest naval buildup since the 2003 Iraq War, amid rising tensions with Iran [3] - Iran has fortified its military presence in the Strait of Hormuz, warning that any U.S. military action could lead to a complete blockade of the strait, which is critical for global oil supply [3] - Market speculation around oil and gas has led to significant stock price increases for companies involved in these sectors, such as Shandong Molong (00568) and Sinopec Oilfield Services (02883) [3] AI Investment Trends - Despite significant investments in AI, the contribution to U.S. GDP growth is projected to be negligible by 2025 due to reliance on imported components [4] - Concerns about potential job losses and economic contraction due to AI advancements have led to declines in stocks like IBM, which fell 13%, marking its largest drop in 25 years [4] - Hardware investments remain strong as companies aim to capitalize on the AI trend, leading to price increases in related sectors such as fiber optics and storage [5] Commodity and Resource Sector - The lithium carbonate market has stabilized, with expectations of increased demand for energy storage solutions as the winter season ends [8] - China National Chemical (00297) and other companies are expected to benefit from rising prices in key agricultural inputs and materials due to supply constraints [6] Individual Company Highlights - China Railway (00390) has acquired a significant silver mining exploration right valued at over 78.7 billion yuan, which could enhance its resource business and overall valuation [9] - The company’s mining segment is expected to contribute approximately 20% to its profits, with a gross margin of over 59%, indicating a shift in its business focus [9][10] - Forecasts for 2026 suggest a net profit of 280 to 310 billion yuan, with substantial growth potential in both resource and engineering sectors [10]

Core Viewpoint - Fosun International has continued its strong growth momentum in 2026, driven by the commercialization of innovative results and deepening global operations, achieving breakthroughs in sectors such as cultural tourism, consumer goods, and innovative pharmaceuticals [1][2]. Group 1: Cultural Tourism and Consumer Growth - During the Spring Festival, Fosun's cultural tourism sector showed robust growth, with Shanghai Yuyuan Mall receiving nearly 1.2 million visitors, a year-on-year increase of over 20% [1] - Club Med's five domestic resorts achieved an average occupancy rate of 90% during the core holiday period [1] - Atlantis Sanya reported a total revenue of 124 million yuan during the Spring Festival holiday, marking a 20% year-on-year increase and setting a historical record for the holiday [1] Group 2: Innovative Pharmaceuticals - Fosun's innovative pharmaceutical sector has seen significant developments, with its subsidiary, Fuhong Hanlin, receiving clinical trial approvals for HLX15-SC from both the Chinese National Medical Products Administration and the FDA [2] - HLX15, a biosimilar to Daratumumab, has a projected global sales potential of approximately 12.88 billion yuan in 2024 [2] - Fosun's innovative drug revenue exceeded 6.7 billion yuan in the first three quarters of 2025, reflecting an 18.09% year-on-year growth [3] Group 3: Strategic Collaborations and Future Growth - Fosun's subsidiary, Yaoyou Pharmaceutical, signed a global exclusive licensing agreement with Pfizer for the oral small molecule GLP-1 drug YP05002, with potential total payments exceeding 2 billion USD [4] - A strategic partnership with Clavis Bio aims to develop innovative therapies, with potential payments up to 7.25 billion USD [4] - The innovative drug sector is expected to enhance Fosun's long-term valuation elasticity, as the company enters a period of concentrated harvest of innovative drug research and commercial growth [5] Group 4: Globalization and Financial Performance - Fosun's overseas revenue reached 53% in the first half of 2025, marking a historical high [6] - The pharmaceutical sector's overseas revenue grew by 184%, surpassing 10 billion yuan, showcasing the company's global capabilities [7] - The company has successfully divested non-core assets, raising significant funds to support its focus on core businesses, with total debt to total capital ratio at 53% as of mid-2025 [8][9]

Group 1 - The core viewpoint of the article highlights that Sociedad Química y Minera de Chile (SQM) has seen a rise in stock price due to improved lithium production forecasts from its joint venture with Codelco, amid a gradual easing of global supply surplus [1] - SQM's stock closed at $73.07, up 1.68%, and pre-market trading showed a further increase of 2.23% to $74.70 [1] - The joint venture, NovaAndino Litio SpA, is projected to produce 233,000 tons of lithium carbonate equivalent in 2025, exceeding previous estimates and the company's own forecast of "close to 230,000 tons" made in November [1] Group 2 - The average price of SQM shares was $72.471, with a market capitalization of $20.872 billion [1] - The stock's price-to-earnings ratio (P/E) is reported at 12.91, while the trailing P/E ratio stands at 30.46 [1] - The 52-week high for SQM shares is $86.13, and the 52-week low is $29.36, indicating significant price volatility [1]

Core Insights - Fosun International has continued its strong growth momentum in 2026, particularly in tourism, consumption, and innovative pharmaceuticals, driven by the commercialization of innovative results and deepening global operations [1][2] Tourism and Consumption - During the Spring Festival, Fosun's tourism and consumption sectors showed robust growth, with Shanghai Yuyuan Mall receiving nearly 1.2 million visitors, a year-on-year increase of over 20% [1] - Club Med's five domestic resorts achieved an average occupancy rate of 90% during the core holiday period [1] - Atlantis Sanya reported a total revenue of 124 million yuan during the Spring Festival, marking a 20% year-on-year increase and setting a record for the holiday [1] Innovative Pharmaceuticals - Fosun's innovative pharmaceutical sector has seen significant developments, with its subsidiary, Fuhong Hanlin, receiving clinical trial approvals for HLX15-SC from both the Chinese National Medical Products Administration and the FDA [2] - HLX15, a biosimilar to Daratumumab, has a projected global sales potential of approximately $12.88 billion in 2024 [2] - Fosun Pharma's innovative drug revenue exceeded 6.7 billion yuan in the first three quarters of 2025, representing an 18.09% year-on-year growth, with innovative drugs accounting for 32% of the pharmaceutical segment [3] Strategic Collaborations and Agreements - Fosun Pharma's subsidiary, Yaoyou Pharmaceutical, signed a global exclusive licensing agreement with Pfizer for the oral GLP-1 drug YP05002, with potential total payments exceeding $2 billion [4] - A strategic cooperation agreement with Clavis Bio could yield up to $7.25 billion in payments for developing innovative therapies [4] - The self-developed small molecule inhibitor FXS6837 has entered a global licensing partnership, and the rare disease treatment Rumaine has received breakthrough therapy designation in Saudi Arabia [4] Globalization and Revenue Growth - Fosun's overseas revenue reached 53% of total revenue in the first half of 2025, marking a historical high [7] - The overseas revenue from Fosun Pharma's innovative drugs grew by 184%, surpassing 10 billion yuan [7] - Club Med's global performance reached 9.25 billion yuan in the first half of 2025, with an 11% increase in operating profit [7] Financial Health and Debt Management - Fosun's total debt-to-capital ratio was 53% in the first half of 2025, with a decrease in debt costs [11] - Significant capital was raised through the sale of stakes in various subsidiaries, including a 3.1 billion euro stake in Luz Saúde and a 7.03 billion euro stake in HAL [11] - The company secured a record offshore syndicated loan of $990 million, the highest in five years, and issued $400 million in bonds [11] Conclusion - With a focus on innovation and globalization, Fosun International is positioned for sustainable growth, enhancing its long-term valuation flexibility as it continues to realize innovative results and deepen its global presence [10][11]

21世纪经济报道记者董鹏 2月24日早盘，中国中铁迅速涨停。 此次异动，源于春节期间其H股的大幅上涨，使得本就处于五年低位的A/H溢价率进一步走低，并在节后刺激其A股出现涨停。 Wind数据显示，节前最后一个交易日，中国中铁A/H溢价率已经降至1.39倍，为2020年7月以来的最低值，而在A股休市期间，其H股又取得了11.5%左右的 涨幅，促使中国中铁节后首日涨停。 而更深层次的原因，则是中国中铁极为明显的估值优势。作为一家营收过万亿、利润稳定在300亿级别的巨无霸，中国中铁此前A股总市值不过1350亿元左 右。 在2025年A股上涨行情中，公司股价反而出现一定幅度的下跌，并且长期处于"破净"状态，2025年至今其市净率始终保持在0.5倍以下。 H股股价大涨助推A股估值 春节前后，中国中铁的基本面并无明显变化，仅有部分卖方机构关注到公司的矿业权竞拍事件。 2月12日，内蒙古兴安盟自然资源局公示，科尔沁右翼前旗复兴屯银铅锌多金属矿1区探矿权，以78.7亿元的价格由中金（兴安盟）矿业有限公司竞得。 中金（兴安盟）矿业有限公司，为中国中铁旗下参股企业，后者通过子公司中铁资源集团持有其30%股权。 对此中信建投发布研 ...